FOSTEMSAVIR TROMETHAMINE

FOSTEMSAVIR TROMETHAMINE was reported 243 times

FOSTEMSAVIR TROMETHAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART ALTERNATION 1 0.0125
1 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 3 0.0108
2 CD4 LYMPHOCYTES INCREASED 2 0.0086
3 MESENTERIC NEOPLASM 1 0.0078
4 VIRAL LOAD ABNORMAL 1 0.0057
5 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0045
6 T-LYMPHOCYTE COUNT DECREASED 3 0.0044
7 MUSCULOSKELETAL DEFORMITY 1 0.0043
8 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 1 0.0039
9 ABDOMINAL WALL HAEMORRHAGE 1 0.0038
10 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 3 0.0034
11 GASTROENTERITIS ROTAVIRUS 1 0.0032
12 ALLERGY TO ARTHROPOD BITE 1 0.0031
13 VIRAL LOAD INCREASED 12 0.0031
14 BLOOD HIV RNA INCREASED 5 0.0028
15 UTERINE MASS 1 0.0024
16 VIROLOGIC FAILURE 9 0.0017
17 DIAPHRAGMATIC PARALYSIS 1 0.0017
18 PRODUCT RESIDUE PRESENT 9 0.0017
19 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
20 VIRAEMIA 2 0.0014
21 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
22 SYPHILIS 1 0.0014
23 VIRAL MUTATION IDENTIFIED 5 0.0014
24 METAPNEUMOVIRUS INFECTION 1 0.0013
25 MUSCLE DISCOMFORT 1 0.0013
26 PATHOGEN RESISTANCE 10 0.0011
27 IDIOSYNCRATIC DRUG REACTION 1 0.0010
28 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
29 BONE DEMINERALISATION 1 0.0009
30 CD4 LYMPHOCYTES DECREASED 2 0.0009
31 STREPTOCOCCAL BACTERAEMIA 1 0.0009
32 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
33 MYELITIS TRANSVERSE 1 0.0007
34 NOROVIRUS INFECTION 1 0.0007
35 SEBORRHOEIC DERMATITIS 1 0.0006
36 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
37 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
38 ABDOMINAL WALL HAEMATOMA 1 0.0005
39 INJECTION SITE NECROSIS 1 0.0005
40 GASTROINTESTINAL TUBE INSERTION 1 0.0004
41 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
42 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
43 LUNG CONSOLIDATION 1 0.0004
44 OXYGEN SATURATION ABNORMAL 1 0.0004
45 PANCREATIC CARCINOMA METASTATIC 1 0.0004
46 VASCULAR GRAFT 1 0.0003
47 ODYNOPHAGIA 2 0.0003
48 EMERGENCY CARE 1 0.0003
49 ALCOHOL USE 1 0.0003
50 PARANASAL SINUS DISCOMFORT 1 0.0003
51 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
52 PURULENT DISCHARGE 1 0.0002
53 LUMBAR VERTEBRAL FRACTURE 1 0.0002
54 RASH VESICULAR 1 0.0002
55 VITAMIN D DEFICIENCY 2 0.0002
56 VITREOUS FLOATERS 2 0.0002
57 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
58 PRODUCT ADMINISTRATION ERROR 4 0.0002
59 PRODUCT SIZE ISSUE 1 0.0002
60 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
61 SWELLING OF EYELID 1 0.0002
62 PHOTOPSIA 1 0.0002
63 PRODUCT PREPARATION ISSUE 1 0.0002
64 POST-TRAUMATIC STRESS DISORDER 1 0.0001
65 EXTRASYSTOLES 1 0.0001
66 PAPULE 1 0.0001
67 ORAL DISORDER 1 0.0001
68 TREATMENT NONCOMPLIANCE 7 0.0001
69 PRODUCT USE COMPLAINT 2 0.0001
70 SENSORY LOSS 1 0.0001
71 STENT PLACEMENT 1 0.0001
72 VENTRICULAR TACHYCARDIA 2 0.0001
73 CANDIDA INFECTION 2 0.0001
74 DRUG RESISTANCE 3 0.0001
75 BLOOD MAGNESIUM DECREASED 1 0.0001
76 ANHEDONIA 3 0.0001
77 RETINAL DETACHMENT 1 0.0001
78 NERVE COMPRESSION 1 0.0001
79 NEPHROPATHY 1 0.0001
80 FLANK PAIN 1 0.0001
81 HOSPICE CARE 1 0.0001
82 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
83 SUDDEN DEATH 1 0.0001
84 RENAL PAIN 1 0.0001
85 BACK INJURY 1 0.0001
86 PULMONARY THROMBOSIS 1 0.0001
87 INJECTION SITE NODULE 1 0.0001
88 DENTAL CARIES 1 0.0001
89 EYE INFECTION 1 0.0001
90 POISONING 1 0.0001
91 GASTROINTESTINAL DISORDER 7 0.0001
92 SARS-COV-2 TEST POSITIVE 1 0.0001
93 EYE HAEMORRHAGE 1 0.0001
94 RASH PRURITIC 4 0.0001
95 DYSPHAGIA 7 0.0001
96 BLOOD TEST ABNORMAL 1 0.0001
97 BLINDNESS UNILATERAL 1 0.0001
98 DIALYSIS 1 0.0001
99 LIVER FUNCTION TEST ABNORMAL 2 0.0001
100 APATHY 1 0.0001
101 HAEMORRHAGE INTRACRANIAL 1 0.0001
102 OSTEOPENIA 1 0.0001
103 TENDONITIS 1 0.0001
104 MUSCLE TIGHTNESS 1 0.0001
105 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
106 SCAR 1 0.0001
107 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
108 EOSINOPHILIA 1 0.0001
109 HEAD DISCOMFORT 1 0.0001
110 GOUT 1 0.0001
111 INJECTION SITE MASS 2 0.0001
112 HEPATIC CIRRHOSIS 1 0.0001
113 DYSPNOEA EXERTIONAL 2 0.0001
114 FRACTURE 1 0.0001
115 FOOT FRACTURE 1 0.0001
116 MUSCULOSKELETAL DISORDER 1 0.0001
117 PRODUCT DOSE OMISSION ISSUE 15 0.0001
118 DISABILITY 1 0.0001
119 HALLUCINATION, VISUAL 1 0.0000
120 RETCHING 1 0.0000
121 BLOOD CREATININE INCREASED 3 0.0000
122 PRODUCT PRESCRIBING ISSUE 1 0.0000
123 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
124 RASH MACULO-PAPULAR 1 0.0000
125 RASH PAPULAR 1 0.0000
126 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
127 PRODUCT PRESCRIBING ERROR 1 0.0000
128 BLOOD PRESSURE FLUCTUATION 1 0.0000
129 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
130 INJECTION SITE URTICARIA 1 0.0000
131 GASTRITIS 1 0.0000
132 TREATMENT FAILURE 3 0.0000
133 MENTAL STATUS CHANGES 1 0.0000
134 OFF LABEL USE 30 0.0000
135 DYSSTASIA 1 0.0000
136 PALPITATIONS 4 0.0000
137 RENAL INJURY 1 0.0000
138 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
139 BLOOD POTASSIUM DECREASED 1 0.0000
140 LACRIMATION INCREASED 1 0.0000
141 ILL-DEFINED DISORDER 2 0.0000
142 BLOOD PRESSURE INCREASED 5 0.0000
143 NERVOUS SYSTEM DISORDER 1 0.0000
144 HIP FRACTURE 1 0.0000
145 VIRAL INFECTION 1 0.0000
146 SKIN DISORDER 1 0.0000
147 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
148 ILLNESS 3 0.0000
149 DELIRIUM 1 0.0000
150 RASH MACULAR 1 0.0000
151 SKIN BURNING SENSATION 2 0.0000
152 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
153 PANIC ATTACK 1 0.0000
154 CHEST PAIN 5 0.0000
155 HYPERSENSITIVITY 5 0.0000
156 EYE SWELLING 1 0.0000
157 COLITIS 1 0.0000
158 CHRONIC KIDNEY DISEASE 2 0.0000
159 HOSPITALISATION 4 0.0000
160 RASH 11 0.0000
161 THROMBOSIS 2 0.0000
162 EMOTIONAL DISTRESS 3 0.0000
163 EXTRA DOSE ADMINISTERED 1 0.0000
164 ANXIETY 7 0.0000
165 OSTEOPOROSIS 1 0.0000
166 POLLAKIURIA 1 0.0000
167 PRODUCT STORAGE ERROR 2 0.0000
168 ANGIOEDEMA 1 0.0000
169 DEHYDRATION 3 0.0000
170 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
171 SKIN IRRITATION 1 0.0000
172 BACK PAIN 5 0.0000
173 NAUSEA 17 0.0000
174 DISEASE RECURRENCE 1 0.0000
175 PRODUCTIVE COUGH 1 0.0000
176 RASH ERYTHEMATOUS 1 0.0000
177 MULTIPLE SCLEROSIS 1 0.0000
178 DRUG INTOLERANCE 2 0.0000
179 HYPOGLYCAEMIA 1 0.0000
180 HEART RATE INCREASED 2 0.0000
181 DIZZINESS 10 0.0000
182 HYPOAESTHESIA 3 0.0000
183 INJECTION SITE PAIN 6 0.0000
184 INFLAMMATION 1 0.0000
185 NERVOUSNESS 1 0.0000
186 MUSCULOSKELETAL PAIN 1 0.0000
187 ASTHENIA 7 0.0000
188 DEATH 16 0.0000
189 ARTHROPATHY 1 0.0000
190 INFLUENZA 2 0.0000
191 URTICARIA 3 0.0000
192 NECK PAIN 1 0.0000
193 PANCYTOPENIA 1 0.0000
194 ABDOMINAL DISCOMFORT 3 0.0000
195 MUSCULAR WEAKNESS 2 0.0000
196 INCORRECT DOSE ADMINISTERED 4 0.0000
197 WHEEZING 1 0.0000
198 DISCOMFORT 1 0.0000
199 NASOPHARYNGITIS 3 0.0000
200 EXPOSURE DURING PREGNANCY 1 0.0000
201 PRODUCT USE ISSUE 3 0.0000
202 GAIT DISTURBANCE 3 0.0000
203 SWELLING FACE 1 0.0000
204 BLOOD PRESSURE DECREASED 1 0.0000
205 DRY SKIN 2 0.0000
206 INJECTION SITE PRURITUS 1 0.0000
207 WEIGHT DECREASED 4 0.0000
208 HYPERTENSION 3 0.0000
209 THERAPY INTERRUPTED 1 0.0000
210 MOBILITY DECREASED 1 0.0000
211 DYSGEUSIA 1 0.0000
212 HALLUCINATION 1 0.0000
213 DEPRESSION 3 0.0000
214 CONDITION AGGRAVATED 4 0.0000
215 DIABETES MELLITUS 1 0.0000
216 PERIPHERAL SWELLING 2 0.0000
217 FATIGUE 10 0.0000
218 PARAESTHESIA 2 0.0000
219 INJECTION SITE HAEMORRHAGE 1 0.0000
220 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
221 DIARRHOEA 8 0.0000
222 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
223 CEREBROVASCULAR ACCIDENT 2 0.0000
224 INTENTIONAL PRODUCT MISUSE 1 0.0000
225 COVID-19 2 0.0000
226 PAIN 7 0.0000
227 INSOMNIA 3 0.0000
228 TACHYCARDIA 1 0.0000
229 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
230 OROPHARYNGEAL PAIN 1 0.0000
231 CARDIAC DISORDER 1 0.0000
232 SWELLING 1 0.0000
233 VOMITING 5 0.0000
234 DRUG INEFFECTIVE 14 0.0000
235 DYSPNOEA 6 0.0000
236 PULMONARY EMBOLISM 1 0.0000
237 MIGRAINE 1 0.0000
238 SYNCOPE 1 0.0000
239 FLUSHING 1 0.0000
240 CHEST DISCOMFORT 1 0.0000
241 HAEMOGLOBIN DECREASED 1 0.0000
242 ABDOMINAL PAIN UPPER 2 0.0000
243 ABDOMINAL DISTENSION 1 0.0000
244 HEADACHE 6 0.0000
245 FALL 3 0.0000
246 SEPSIS 1 0.0000
247 ASTHMA 1 0.0000
248 CHILLS 1 0.0000
249 DISEASE PROGRESSION 1 0.0000
250 OEDEMA PERIPHERAL 1 0.0000
251 INJECTION SITE ERYTHEMA 1 0.0000
252 PRURITUS 3 0.0000
253 HYPERHIDROSIS 1 0.0000
254 COUGH 2 0.0000
255 PAIN IN EXTREMITY 2 0.0000
256 DRUG INTERACTION 1 0.0000
257 CONFUSIONAL STATE 1 0.0000
258 PNEUMONIA 2 0.0000
259 MYALGIA 1 0.0000
260 PYREXIA 2 0.0000
261 BLOOD GLUCOSE INCREASED 1 0.0000
262 ANAEMIA 1 0.0000
263 ALOPECIA 1 0.0000
264 SOMNOLENCE 1 0.0000
265 ERYTHEMA 1 0.0000
266 ARTHRALGIA 2 0.0000
267 MALAISE 2 0.0000
268 DECREASED APPETITE 1 0.0000
269 ABDOMINAL PAIN 1 0.0000
270 FEELING ABNORMAL 1 0.0000
271 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000